15 results
2:00 - Salmonella typhi, Sushant Sahastrabuddhe, IVI.
20:32 - Schistosomiasis, Robert Bergquist, Geospatial Health.
36:26 - HPV, Aimee Kreimer, NCI/NIH.
52:46 - Novel OPV, Ananda Bandyopadhyay,...
Landscape of typhoid conjugate vaccines, next steps and challenges. Rationale and landscape for non-typhoidal salmonella vaccines.
Key arguments for schistosomiasis vaccine development and update on vaccine candidates
Role of CHMI in malaria vaccine development, rationale for human infection studies in semi-immune adults in Kenya, work in progress and future developments
Why has HIV vaccine development been so challenging, update on HIV vaccine clinical development, and scientific advances fueling vaccine discovery
Options for pandemic influenza vaccines and challenges of universal influenza vaccine development
The COVID-19 candidate vaccine landscape and tracker database compiles detailed information on COVID-19 vaccine candidates in development.
The landscape is updated regularly - twice a week...
Viral-vectored vaccines against Ebola, Chikungunya, and COVID-19
Recent results in TB vaccine R&D are game-changing: what key challenges and opportunities remain?
3:28 - Nucleic acid vaccines: Is it all done? Christian Mandl. 21:37 - Viral Vectored vaccine platform technologies, Sarah Gilbert. 33:49 - Adjuvants, . 45:16 - Block 1 Q&A, Christian Mandl, Nathalie...
Final agenda as of February 7, 2022. Includes registration link
Learnings from COVID-19 and applications to other global health challenges. Topics include how a correlate of protection (CoP) is discovered and applied for vaccine development; identification of a...